| Acquirer | Target | Price |
|---|---|---|
| DiaSorin S.p.A. | Focus Diagnostics Inc. | $300 million |
| Sun Pharmaceutical Industries Ltd. | 14 prescription drug brands | $293 million |
| Encore Rehabilitation Services, LLC | Contract therapy business | $65 million |
| PuraCap Pharmaceuticals | Epic Pharma, LLC | $550 million |
| MEDNAX, Inc. | Mid-Missouri Neonatology, LLC | N/A |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
